NEW YORK, April 17 (LPC) – The calendar for US leveraged
loans is at the highest point of the year with new deals
including drug developer Catalent Pharma Solutions’ US$1.2bn
purchase of gene-therapy company Paragon Bioservices and private
equity firm Apollo Global’s US$1.1bn acquisition of Smart &
Final Stores providing a boost.